Quest Diagnostics, Inc. (DGX)

HEALTH CARE: HEALTH CARE SERVICES
SIC: SERVICES-MEDICAL LABORATORIES

500 PLAZA DRIVE SECAUCUS, NJ 07094

Quest Diagnostics is a provider of diagnostic testing, information and services. Co. is a provider of: clinical testing, which is generally is performed on whole blood, serum, plasma and other body fluids, such as urine, and specimens such as microbiology samples; and anatomic pathology services principally for the detection of cancer and are performed on tissues, such as biopsies, and other samples, such as human cells. Co.'s other operating segments include its non-clinical testing businesses and consist of its risk assessment services, clinical trials testing, healthcare information technology, and diagnostics products businesses.

Data based on most recent fiscal year report
Market Cap13.48 Billion Shares Outstanding136.3 Million Avg Volume1.595 Million
1-Yr BETA vs S&P TR0.678 Current Ratio1.24 Quick Ratio1.15
View SEC Filings from DGX instead.
Q1 2019 All Institutions Hedge Funds 1
To trade DGX now:
Filers who had this stock in their top 10: 0 0 (0.0%)
13F Filers holding this stock: 624 50 (5.1%)
Aggregate 13F shares on 03/31/2019: 122.853 Million 5.681 Million
Aggregate 13F shares on 12/31/2018: 120.404 Million 8.906 Million
Percent change: 2.03% -36.21%
Funds creating new positions: 93 9
Funds Adding to an existing position: 223 13
Funds closing out their position: 55 10
Funds reducing their position: 198 23
1 hedge funds as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding DGX (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

365.1 Thousand total shares from 3 transactions

Exercise Derivative Conversion (M)

365.1 Thousand total shares from 3 transactions

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

RUSCKOWSKI STEPHEN H CHAIRMAN, PRESIDENT AND CEO

  • Officer
  • Director
213,049 2019-06-13 6

GUINAN MARK EXECUTIVE VICE PRESIDENT & CFO

  • Officer
66,017 2019-06-13 6

GLAXOSMITHKLINE PLC

  • 10% Owner
0 2019-06-11 0

PFEIFFER GARY M

  • Director
80,695 2019-06-06 1

BRITELL JENNE K

  • Director
74,278 2019-05-30 0

LEIDEN JEFFREY M CEO & PRESIDENT

  • Officer
  • Director
106,727 2019-05-24 0

HAGEMANN ROBERT

  • Director
74,674 2019-05-22 0

MOHAPATRA SURYA N

  • Director
37,247 2019-05-15 0

WILENSKY GAIL R

  • Director
28,326 2019-05-14 2

RING TIMOTHY M

  • Director
18,576 2019-05-14 5

STANZIONE DANIEL

  • Director
38,041 2019-05-14 1

MAIN TIMOTHY L

  • Director
18,057 2019-05-14 1

GREGG VICKY B

  • Director
12,125 2019-05-14 1

TORLEY HELEN

  • Director
3,366 2019-05-14 3

MORRISON DENISE M

  • Director
2,212 2019-05-14 4

DEPPE MICHAEL J VP, CORP. CONTROLLER & CAO

  • Officer
24,289 2019-05-13 2

DAVIS J. E. EVP, GENERAL DIAGNOSTICS

  • Officer
36,534 2019-04-24 7

DOHERTY CATHERINE T. SVP, GROUP EXEC. CLIN. FRAN.

  • Officer
71,450 2019-04-04 6

PREVOZNIK MICHAEL E SVP & GENERAL COUNSEL

  • Officer
44,467 2019-03-01 6

CUNNINGHAM EVERETT SVP, COMMERCIAL

  • Officer
39,032 2019-03-01 7

KLUG ROBERT A VP, CORPORATE CONTROLLER

  • Officer
6,261 2019-03-01 7

EGLINTON MANNER CARRIE SVP, ADVANCED DIAGNOSTICS

  • Officer
22,793 2019-02-25 4

ORDONEZ KATHY

  • Director
56,767 2019-02-15 0

COHEN JON R SVP & GROUP EXEC. DIAG. SOL.

  • Officer
31,757 2018-03-08 0

ZIEGLER JOHN B

  • Director
16,557 2017-02-22 0

BONGIORNO THOMAS F SVP AND CAO

  • Officer
No longer subject to file 2016-12-01 0

BALDWIN JOHN C MD

  • Director
12,949 2015-08-12 0

HAYDON JOHN B. SVP, OPERATIONS

  • Officer
19,890 2014-02-13 0

BUEHLER WILLIAM F

  • Director
26,225 2014-02-12 0

MILLER JOAN ELIZABETH SVP-ONCOLOGY & NEUROLOGY SRVCS

  • Officer
90,279 2012-02-29 0

SIMMONS WAYNE R. VICE PRESIDENT, OPERATIONS

  • Officer
47,752 2011-06-16 0

HAGGERTY ROSANNE

  • Director
9,334 2010-05-06 0

Insider Transactions Last 60 Days

Reporting Owners Transaction Date Transaction Code Shares Share Price Acquired or Disposed Shares Owned Following Transaction Combined shares owned after filing Direct/Indirect Ownership 10b-5

GUINAN MARK - Officer EXECUTIVE VICE PRESIDENT & CFO

2019-06-13 S 73,005 $100.00 d 66,017 66,017.00 direct

RUSCKOWSKI STEPHEN H - Director - Officer CHAIRMAN, PRESIDENT AND CEO

2019-06-13 S 244,565 $100.00 d 213,049 213,049.00 direct

GUINAN MARK - Officer EXECUTIVE VICE PRESIDENT & CFO

2019-06-13 M 73,005 $52.17 a 139,022 66,017.00 direct

RUSCKOWSKI STEPHEN H - Director - Officer CHAIRMAN, PRESIDENT AND CEO

2019-06-13 M 244,565 $52.17 a 457,614 213,049.00 direct

GUINAN MARK - Officer EXECUTIVE VICE PRESIDENT & CFO

2019-06-13 M 73,005 $52.17 d 0 66,017.00 direct

RUSCKOWSKI STEPHEN H - Director - Officer CHAIRMAN, PRESIDENT AND CEO

2019-06-13 M 244,565 $52.17 d 0 213,049.00 direct

MORRISON DENISE M - Director

2019-05-14 A 1,722 a 2,212 2,212.00 direct

STANZIONE DANIEL - Director

2019-05-14 A 1,722 a 38,041 38,041.00 direct

PFEIFFER GARY M - Director

2019-05-14 A 1,722 a 19,563 19,563.00 direct

RING TIMOTHY M - Director

2019-05-14 A 1,722 a 18,576 18,576.00 direct

MAIN TIMOTHY L - Director

2019-05-14 A 1,722 a 18,057 18,057.00 direct

GREGG VICKY B - Director

2019-05-14 A 1,722 a 12,125 12,125.00 direct

WILENSKY GAIL R - Director

2019-05-14 A 1,722 a 14,951 28,326.00 direct

TORLEY HELEN - Director

2019-05-14 A 1,722 a 3,366 3,366.00 direct

DEPPE MICHAEL J - Officer VP, CORP. CONTROLLER & CAO

2019-05-13 A 608 a 608 24,289.00 direct

DEPPE MICHAEL J - Officer VP, CORP. CONTROLLER & CAO

2019-05-13 A 52 a 23,671 24,289.00 direct

DAVIS J. E. - Officer EVP, GENERAL DIAGNOSTICS

2019-04-24 M 47,574 $60.68 a 84,108 36,534.00 direct yes

DAVIS J. E. - Officer EVP, GENERAL DIAGNOSTICS

2019-04-24 M 47,574 $60.68 d 0 36,534.00 direct yes

DAVIS J. E. - Officer EVP, GENERAL DIAGNOSTICS

2019-04-24 S 47,574 $95.00 d 36,534 36,534.00 direct yes
Click here to report any possible errors with this stock listing.

Elevate your investments